The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS Clinical Trials Group Protocol 850)

Joseph J. Eron*, Laura M. Smeaton, Susan A. Fiscus, Roy M. Gulick, Judith S. Currier, Jeffrey L. Lennox, Richard T. D'Aquila, Michael D. Rogers, Roger Tung, Robert L. Murphy

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS Clinical Trials Group Protocol 850)'. Together they form a unique fingerprint.

Medicine & Life Sciences